Phillip G. Febbo: I am super excited to move back closer to patient testing and to take on the role of Chief Science Officer and Chief Medical Officer at Veracyte.

Phillip G. Febbo: I am super excited to move back closer to patient testing and to take on the role of Chief Science Officer and Chief Medical Officer at Veracyte.

Quoting Phillip G. Febbo, Board Member and Chair or Governance Committee at the Reagan-Udall Foundation for the FDA, on LinkedIn:

“I am super excited to move back closer to patient testing and to take on the role of Chief Science Officer and Chief Medical Officer at Veracyte. A broader role with a more defined focus on improving cancer patient management and outcomes. Looking forward to getting back to direct impact on patient care, healthcare, and a thriving business in today’s environment!”

Phillip G. Febbo: I am super excited to move back closer to patient testing and to take on the role of Chief Science Officer and Chief Medical Officer at Veracyte.

Source: Phillip G. Febbo/LinkedIn.

cancer health care OncoDaily Oncology patient care Phillip Febbo Veracyte